Northern Trust Corp Athira Pharma, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 53,609 shares of ATHA stock, worth $34,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,609

Previous 53,609 -0.0%

Holding current value

$34,845

Previous $142,000 83.1%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.92 - $2.71 $746 - $1,054	389 Added 0.73%	53,609 $142,000
Q1 2024 May 14, 2024	SELL	$2.24 - $4.15 $2,329 - $4,316	-1,040 Reduced 1.92%	53,220 $145,000
Q4 2023 Feb 13, 2024	SELL	$1.39 - $2.46 $358 - $634	-258 Reduced 0.47%	54,260 $131,000
Q3 2023 Nov 13, 2023	SELL	$1.9 - $3.16 $5,510 - $9,164	-2,900 Reduced 5.05%	54,518 $110,000
Q2 2023 Aug 11, 2023	SELL	$2.36 - $3.59 $526,801 - $801,363	-223,221 Reduced 79.54%	57,418 $169,000
Q1 2023 May 15, 2023	BUY	$2.26 - $4.22 $13,530 - $25,265	5,987 Added 2.18%	280,639 $701,000
Q4 2022 Feb 13, 2023	SELL	$2.76 - $3.71 $4,529 - $6,088	-1,641 Reduced 0.59%	274,652 $870,000
Q3 2022 Nov 14, 2022	SELL	$2.93 - $3.96 $10,990 - $14,853	-3,751 Reduced 1.34%	276,293 $820,000
Q2 2022 Aug 12, 2022	BUY	$2.74 - $13.43 $10,061 - $49,314	3,672 Added 1.33%	280,044 $855,000
Q1 2022 May 13, 2022	SELL	$8.96 - $13.51 $110,342 - $166,375	-12,315 Reduced 4.27%	276,372 $3.73 Million
Q4 2021 Feb 08, 2022	SELL	$9.17 - $16.39 $3,530 - $6,310	-385 Reduced 0.13%	288,687 $3.76 Million
Q3 2021 Nov 15, 2021	BUY	$9.15 - $11.09 $1.72 Million - $2.09 Million	188,287 Added 186.82%	289,072 $2.71 Million
Q2 2021 Aug 13, 2021	SELL	$10.24 - $20.87 $530,432 - $1.08 Million	-51,800 Reduced 33.95%	100,785 $1.03 Million
Q1 2021 May 12, 2021	BUY	$16.9 - $29.77 $122,998 - $216,666	7,278 Added 5.01%	152,585 $2.81 Million
Q4 2020 Feb 11, 2021	BUY	$16.48 - $34.3 $2.39 Million - $4.98 Million	145,307 New	145,307 $4.98 Million

Others Institutions Holding ATHA

# of Institutions

Shares Held

16.9M

Call Options Held

112K

Put Options Held

68K

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.6M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Athira Pharma, Inc. Transaction History